Effect of punica granatum L . (peel) on ulcerative colitis disease
Phase 2
- Conditions
- ulcerative colitis.Noninfective enteritis and colitise
- Registration Number
- IRCT2014040617156N1
- Lead Sponsor
- Vice chancellor for research, Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
patients 18 and up to 70 years old; ulcerative colitis identified by clinical criteria, laboratory and endoscopic disease is confirmed; informed consent. Exclusion criteria: addiction; lack of consent to participate or continue to participate in the study; pregnant women; a history of hypersensitivity to the ingredients of pomegranate; taking prednisone above 15 mg daily and / or cyclosporine and / or infleximab.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical features of patients with ulcerative colitis. Timepoint: 4 weeks after intervention. Method of measurement: Lichtiger Questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: 4 weeks after the start of the intervention. Method of measurement: Patient monitoring.